PDB Short entry for 1VHR HEADER HYDROLASE 20-FEB-96 1VHR TITLE HUMAN VH1-RELATED DUAL-SPECIFICITY PHOSPHATASE COMPND MOL_ID: 1; COMPND 2 MOLECULE: HUMAN VH1-RELATED DUAL-SPECIFICITY PHOSPHATASE VHR; COMPND 3 CHAIN: A, B; COMPND 4 SYNONYM: VHR; COMPND 5 EC: 3.1.3.48; COMPND 6 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 6 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 7 EXPRESSION_SYSTEM_STRAIN: BL21(DE3); SOURCE 8 EXPRESSION_SYSTEM_PLASMID: PT7-7-VHR; SOURCE 9 OTHER_DETAILS: ORIGINAL GENE GDB\:DUSP3; VHR, CHROMOSOME MAP SOURCE 10 POSITION 17Q21 KEYWDS HYDROLASE, PROTEIN DUAL-SPECIFICITY PHOSPHATASE EXPDTA X-RAY DIFFRACTION AUTHOR J.YUVANIYAMA,J.M.DENU,J.E.DIXON,M.A.SAPER REVDAT 3 14-FEB-24 1VHR 1 REMARK REVDAT 2 24-FEB-09 1VHR 1 VERSN REVDAT 1 20-JUN-96 1VHR 0 JRNL AUTH J.YUVANIYAMA,J.M.DENU,J.E.DIXON,M.A.SAPER JRNL TITL CRYSTAL STRUCTURE OF THE DUAL SPECIFICITY PROTEIN JRNL TITL 2 PHOSPHATASE VHR. JRNL REF SCIENCE V. 272 1328 1996 JRNL REFN ISSN 0036-8075 JRNL PMID 8650541 REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH J.M.DENU,G.ZHOU,L.WU,R.ZHAO,J.YUVANIYAMA,M.A.SAPER,J.E.DIXON REMARK 1 TITL THE PURIFICATION AND CHARACTERIZATION OF A HUMAN REMARK 1 TITL 2 DUAL-SPECIFIC PROTEIN TYROSINE PHOSPHATASE REMARK 1 REF J.BIOL.CHEM. V. 270 3796 1995 REMARK 1 REFN ISSN 0021-9258 REMARK 1 REFERENCE 2 REMARK 1 AUTH G.ZHOU,J.M.DENU,L.WU,J.E.DIXON REMARK 1 TITL THE CATALYTIC ROLE OF CYS124 IN THE DUAL SPECIFICITY REMARK 1 TITL 2 PHOSPHATASE VHR REMARK 1 REF J.BIOL.CHEM. V. 269 28084 1994 REMARK 1 REFN ISSN 0021-9258 REMARK 1 REFERENCE 3 REMARK 1 AUTH T.ISHIBASHI,D.P.BOTTARO,A.CHAN,T.MIKI,S.A.AARONSON REMARK 1 TITL EXPRESSION CLONING OF A HUMAN DUAL-SPECIFICITY PHOSPHATASE REMARK 1 REF PROC.NATL.ACAD.SCI.USA V. 89 12170 1992 REMARK 1 REFN ISSN 0027-8424 REMARK 2 REMARK 2 RESOLUTION. 2.10 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : X-PLOR 3.1 REMARK 3 AUTHORS : BRUNGER REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.10 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 10.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : NULL REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 86.4 REMARK 3 NUMBER OF REFLECTIONS : 18746 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : NULL REMARK 3 FREE R VALUE TEST SET SELECTION : NULL REMARK 3 R VALUE (WORKING SET) : 0.176 REMARK 3 FREE R VALUE : 0.254 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 9.960 REMARK 3 FREE R VALUE TEST SET COUNT : NULL REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : NULL REMARK 3 BIN RESOLUTION RANGE HIGH (A) : NULL REMARK 3 BIN RESOLUTION RANGE LOW (A) : NULL REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 REFLECTIONS IN BIN (WORKING SET) : NULL REMARK 3 BIN R VALUE (WORKING SET) : NULL REMARK 3 BIN FREE R VALUE : NULL REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 BIN FREE R VALUE TEST SET COUNT : NULL REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2768 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 20 REMARK 3 SOLVENT ATOMS : 141 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 20.70 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM SIGMAA (A) : NULL REMARK 3 LOW RESOLUTION CUTOFF (A) : NULL REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM C-V SIGMAA (A) : NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.016 REMARK 3 BOND ANGLES (DEGREES) : 1.654 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 23.72 REMARK 3 IMPROPER ANGLES (DEGREES) : 1.870 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : NULL REMARK 3 TOPOLOGY FILE 1 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 1VHR COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY BNL. REMARK 100 THE DEPOSITION ID IS D_1000177038. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 27-NOV-94 REMARK 200 TEMPERATURE (KELVIN) : NULL REMARK 200 PH : 7.0 REMARK 200 NUMBER OF CRYSTALS USED : NULL REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : NULL REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.5418 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : AREA DETECTOR REMARK 200 DETECTOR MANUFACTURER : XUONG-HAMLIN MULTIWIRE REMARK 200 INTENSITY-INTEGRATION SOFTWARE : MADNES, XDS REMARK 200 DATA SCALING SOFTWARE : NULL REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 18952 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.100 REMARK 200 RESOLUTION RANGE LOW (A) : 90.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 86.4 REMARK 200 DATA REDUNDANCY : 2.000 REMARK 200 R MERGE (I) : 0.05500 REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : NULL REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : NULL REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : NULL REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: NULL REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MIR SOFTWARE USED : PHASES REMARK 200 STARTING MODEL FOR MOLECULAR REPLACEMENT: NULL REMARK 200 SOFTWARE USED: X-PLOR 3.1 REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 47.50 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.32 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: THE FULL-LENGTH VHR (RESIDUES 2 - 185) REMARK 280 WAS CRYSTALLIZED AT A CONCENTRATION OF 5-6 MG/ML WITH 14% REMARK 280 POLYETHYLENE GLYCOL 4000, 22.5 MM LITHIUM SULFATE, 50 MM HEPES REMARK 280 PH 7.0, AND 0.05% BETA-MERCAPTOETHANOL IN A HANGING DROP OF 20 REMARK 280 MICROLITERS. THE DROP WAS EQUILIBRATED AGAINST 1 ML OF TWICE THE REMARK 280 CONCENTRATION OF PRECIPITANT SOLUTION AT 23 DEGREE CELSIUS., REMARK 280 VAPOR DIFFUSION - HANGING DROP, TEMPERATURE 296K, VAPOR REMARK 280 DIFFUSION, HANGING DROP REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 30.02000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 SER A 2 REMARK 465 GLY A 3 REMARK 465 SER A 4 REMARK 465 PHE A 5 REMARK 465 GLU A 6 REMARK 465 LEU A 7 REMARK 465 SER B 2 REMARK 465 GLY B 3 REMARK 465 SER B 4 REMARK 465 PHE B 5 REMARK 465 GLU B 6 REMARK 465 LEU B 7 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 SER A 20 144.76 179.84 REMARK 500 ASP A 47 78.50 -104.38 REMARK 500 ASP A 80 -8.86 84.29 REMARK 500 CYS A 124 -148.12 -146.66 REMARK 500 ASP B 18 -174.02 -68.37 REMARK 500 ALA B 63 44.04 -146.14 REMARK 500 CYS B 124 -143.64 -141.64 REMARK 500 SER B 129 -61.06 -122.54 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: RCA REMARK 800 EVIDENCE_CODE: UNKNOWN REMARK 800 SITE_DESCRIPTION: DESIGNATED RECOGNITION REGION IN PRIMARY REMARK 800 REFERENCE. PROPOSED TO AFFECT SUBSTRATE SPECIFICITY. REMARK 800 REMARK 800 SITE_IDENTIFIER: RCB REMARK 800 EVIDENCE_CODE: UNKNOWN REMARK 800 SITE_DESCRIPTION: DESIGNATED RECOGNITION REGION IN PRIMARY REMARK 800 REFERENCE. PROPOSED TO AFFECT SUBSTRATE SPECIFICITY. REMARK 800 REMARK 800 SITE_IDENTIFIER: VRA REMARK 800 EVIDENCE_CODE: UNKNOWN REMARK 800 SITE_DESCRIPTION: THE REGION CONTAINING HIGH VARIATION AMONG THE REMARK 800 DUAL-SPECIFICITY PHOSPHATASES AND THE PROTEIN TYROSINE REMARK 800 PHOSPHATASES. REMARK 800 REMARK 800 SITE_IDENTIFIER: VRB REMARK 800 EVIDENCE_CODE: UNKNOWN REMARK 800 SITE_DESCRIPTION: THE REGION CONTAINING HIGH VARIATION AMONG THE REMARK 800 DUAL-SPECIFICITY PHOSPHATASES AND THE PROTEIN TYROSINE REMARK 800 PHOSPHATASES. REMARK 800 REMARK 800 SITE_IDENTIFIER: GAA REMARK 800 EVIDENCE_CODE: UNKNOWN REMARK 800 SITE_DESCRIPTION: THE LOOP CONTAINING THE PUTATIVE GENERAL ACID REMARK 800 ASP 92. REMARK 800 REMARK 800 SITE_IDENTIFIER: GAB REMARK 800 EVIDENCE_CODE: UNKNOWN REMARK 800 SITE_DESCRIPTION: THE LOOP CONTAINING THE PUTATIVE GENERAL ACID REMARK 800 ASP 92. REMARK 800 REMARK 800 SITE_IDENTIFIER: PLA REMARK 800 EVIDENCE_CODE: UNKNOWN REMARK 800 SITE_DESCRIPTION: PHOSPHATE BINDING LOOP INCLUDING CATALYTIC REMARK 800 NUCLEOPHILE CYS 130 REMARK 800 REMARK 800 SITE_IDENTIFIER: PLB REMARK 800 EVIDENCE_CODE: UNKNOWN REMARK 800 SITE_DESCRIPTION: PHOSPHATE BINDING LOOP INCLUDING CATALYTIC REMARK 800 NUCLEOPHILE CYS 130 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 B 502 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EPE A 401 DBREF 1VHR A 2 185 UNP P51452 DUS3_HUMAN 2 185 DBREF 1VHR B 2 185 UNP P51452 DUS3_HUMAN 2 185 SEQRES 1 A 184 SER GLY SER PHE GLU LEU SER VAL GLN ASP LEU ASN ASP SEQRES 2 A 184 LEU LEU SER ASP GLY SER GLY CYS TYR SER LEU PRO SER SEQRES 3 A 184 GLN PRO CYS ASN GLU VAL THR PRO ARG ILE TYR VAL GLY SEQRES 4 A 184 ASN ALA SER VAL ALA GLN ASP ILE PRO LYS LEU GLN LYS SEQRES 5 A 184 LEU GLY ILE THR HIS VAL LEU ASN ALA ALA GLU GLY ARG SEQRES 6 A 184 SER PHE MET HIS VAL ASN THR ASN ALA ASN PHE TYR LYS SEQRES 7 A 184 ASP SER GLY ILE THR TYR LEU GLY ILE LYS ALA ASN ASP SEQRES 8 A 184 THR GLN GLU PHE ASN LEU SER ALA TYR PHE GLU ARG ALA SEQRES 9 A 184 ALA ASP PHE ILE ASP GLN ALA LEU ALA GLN LYS ASN GLY SEQRES 10 A 184 ARG VAL LEU VAL HIS CYS ARG GLU GLY TYR SER ARG SER SEQRES 11 A 184 PRO THR LEU VAL ILE ALA TYR LEU MET MET ARG GLN LYS SEQRES 12 A 184 MET ASP VAL LYS SER ALA LEU SER ILE VAL ARG GLN ASN SEQRES 13 A 184 ARG GLU ILE GLY PRO ASN ASP GLY PHE LEU ALA GLN LEU SEQRES 14 A 184 CYS GLN LEU ASN ASP ARG LEU ALA LYS GLU GLY LYS LEU SEQRES 15 A 184 LYS PRO SEQRES 1 B 184 SER GLY SER PHE GLU LEU SER VAL GLN ASP LEU ASN ASP SEQRES 2 B 184 LEU LEU SER ASP GLY SER GLY CYS TYR SER LEU PRO SER SEQRES 3 B 184 GLN PRO CYS ASN GLU VAL THR PRO ARG ILE TYR VAL GLY SEQRES 4 B 184 ASN ALA SER VAL ALA GLN ASP ILE PRO LYS LEU GLN LYS SEQRES 5 B 184 LEU GLY ILE THR HIS VAL LEU ASN ALA ALA GLU GLY ARG SEQRES 6 B 184 SER PHE MET HIS VAL ASN THR ASN ALA ASN PHE TYR LYS SEQRES 7 B 184 ASP SER GLY ILE THR TYR LEU GLY ILE LYS ALA ASN ASP SEQRES 8 B 184 THR GLN GLU PHE ASN LEU SER ALA TYR PHE GLU ARG ALA SEQRES 9 B 184 ALA ASP PHE ILE ASP GLN ALA LEU ALA GLN LYS ASN GLY SEQRES 10 B 184 ARG VAL LEU VAL HIS CYS ARG GLU GLY TYR SER ARG SER SEQRES 11 B 184 PRO THR LEU VAL ILE ALA TYR LEU MET MET ARG GLN LYS SEQRES 12 B 184 MET ASP VAL LYS SER ALA LEU SER ILE VAL ARG GLN ASN SEQRES 13 B 184 ARG GLU ILE GLY PRO ASN ASP GLY PHE LEU ALA GLN LEU SEQRES 14 B 184 CYS GLN LEU ASN ASP ARG LEU ALA LYS GLU GLY LYS LEU SEQRES 15 B 184 LYS PRO HET EPE A 401 15 HET SO4 B 502 5 HETNAM EPE 4-(2-HYDROXYETHYL)-1-PIPERAZINE ETHANESULFONIC ACID HETNAM SO4 SULFATE ION HETSYN EPE HEPES FORMUL 3 EPE C8 H18 N2 O4 S FORMUL 4 SO4 O4 S 2- FORMUL 5 HOH *141(H2 O) HELIX 1 1 VAL A 9 LEU A 16 1 8 HELIX 2 2 ALA A 42 ALA A 45 1 4 HELIX 3 3 ILE A 48 LEU A 54 1 7 HELIX 4 4 ALA A 75 TYR A 78 1 4 HELIX 5 5 LEU A 98 LEU A 113 5 16 HELIX 6 6 ARG A 130 ARG A 142 1 13 HELIX 7 7 VAL A 147 ASN A 157 1 11 HELIX 8 8 ASP A 164 LYS A 179 1 16 HELIX 9 9 VAL B 9 LEU B 16 1 8 HELIX 10 10 ALA B 42 ALA B 45 1 4 HELIX 11 11 ILE B 48 LYS B 53 1 6 HELIX 12 12 LEU B 98 ALA B 114 5 17 HELIX 13 13 ARG B 130 GLN B 143 1 14 HELIX 14 14 VAL B 147 ASN B 157 1 11 HELIX 15 15 ASP B 164 LYS B 179 1 16 SHEET 1 A 5 THR A 84 GLY A 87 0 SHEET 2 A 5 HIS A 58 ASN A 61 1 N VAL A 59 O THR A 84 SHEET 3 A 5 VAL A 120 HIS A 123 1 N LEU A 121 O HIS A 58 SHEET 4 A 5 ILE A 37 GLY A 40 1 N TYR A 38 O VAL A 120 SHEET 5 A 5 CYS A 30 THR A 34 -1 N THR A 34 O ILE A 37 SHEET 1 B 5 THR B 84 GLY B 87 0 SHEET 2 B 5 HIS B 58 ASN B 61 1 N VAL B 59 O THR B 84 SHEET 3 B 5 VAL B 120 HIS B 123 1 N LEU B 121 O HIS B 58 SHEET 4 B 5 ILE B 37 GLY B 40 1 N TYR B 38 O VAL B 120 SHEET 5 B 5 CYS B 30 THR B 34 -1 N THR B 34 O ILE B 37 SITE 1 RCA 11 GLY A 19 SER A 20 GLY A 21 CYS A 22 SITE 2 RCA 11 TYR A 23 SER A 24 LEU A 25 PRO A 26 SITE 3 RCA 11 SER A 27 GLN A 28 PRO A 29 SITE 1 RCB 11 GLY B 19 SER B 20 GLY B 21 CYS B 22 SITE 2 RCB 11 TYR B 23 SER B 24 LEU B 25 PRO B 26 SITE 3 RCB 11 SER B 27 GLN B 28 PRO B 29 SITE 1 VRA 21 ALA A 62 ALA A 63 GLU A 64 GLY A 65 SITE 2 VRA 21 ARG A 66 SER A 67 PHE A 68 MET A 69 SITE 3 VRA 21 HIS A 70 VAL A 71 ASN A 72 THR A 73 SITE 4 VRA 21 ASN A 74 ALA A 75 ASN A 76 PHE A 77 SITE 5 VRA 21 TYR A 78 LYS A 79 ASP A 80 SER A 81 SITE 6 VRA 21 GLY A 82 SITE 1 VRB 21 ALA B 62 ALA B 63 GLU B 64 GLY B 65 SITE 2 VRB 21 ARG B 66 SER B 67 PHE B 68 MET B 69 SITE 3 VRB 21 HIS B 70 VAL B 71 ASN B 72 THR B 73 SITE 4 VRB 21 ASN B 74 ALA B 75 ASN B 76 PHE B 77 SITE 5 VRB 21 TYR B 78 LYS B 79 ASP B 80 SER B 81 SITE 6 VRB 21 GLY B 82 SITE 1 GAA 11 ILE A 88 LYS A 89 ALA A 90 ASN A 91 SITE 2 GAA 11 ASP A 92 THR A 93 GLN A 94 GLU A 95 SITE 3 GAA 11 PHE A 96 ASN A 97 LEU A 98 SITE 1 GAB 11 ILE B 88 LYS B 89 ALA B 90 ASN B 91 SITE 2 GAB 11 ASP B 92 THR B 93 GLN B 94 GLU B 95 SITE 3 GAB 11 PHE B 96 ASN B 97 LEU B 98 SITE 1 PLA 9 HIS A 123 CYS A 124 ARG A 125 GLU A 126 SITE 2 PLA 9 GLY A 127 TYR A 128 SER A 129 ARG A 130 SITE 3 PLA 9 SER A 131 SITE 1 PLB 9 HIS B 123 CYS B 124 ARG B 125 GLU B 126 SITE 2 PLB 9 GLY B 127 TYR B 128 SER B 129 ARG B 130 SITE 3 PLB 9 SER B 131 SITE 1 AC1 9 ASP B 92 CYS B 124 ARG B 125 GLU B 126 SITE 2 AC1 9 GLY B 127 TYR B 128 SER B 129 ARG B 130 SITE 3 AC1 9 HOH B 657 SITE 1 AC2 8 ASP A 92 CYS A 124 ARG A 125 GLU A 126 SITE 2 AC2 8 GLY A 127 TYR A 128 SER A 129 ARG A 130 CRYST1 61.148 60.040 52.016 90.00 98.35 90.00 P 1 21 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.016354 0.000000 0.002400 0.00000 SCALE2 0.000000 0.016656 0.000000 0.00000 SCALE3 0.000000 0.000000 0.019431 0.00000 MTRIX1 1 -0.962481 -0.060958 -0.264412 28.16632 1 MTRIX2 1 -0.050633 0.997671 -0.045694 29.73183 1 MTRIX3 1 0.266582 -0.030591 -0.963327 25.95833 1